Evaluation of the Regenerative Medicine & Nanomedicine Initiative – Long descriptions 
                              
                              
                              
                           Figure 3 - Scatterplot of average of relative citations (ARC) and specialization index (SI) for top 16 productive countries in regenerative medicine 2004-2010 
 
        
            Country 
            SI 
            ARC 
            N pub 
         
     
    
        
            United States 
            1.275676481 
            1.29 
            15047 
         
        
            Japan 
            1.426434715 
            0.90 
            4052 
         
        
            Germany 
            1.289020109 
            1.12 
            3875 
         
        
            United Kingdom 
            1.018432548 
            1.22 
            3212 
         
        
            China 
            0.886100262 
            0.59 
            3195 
         
        
            Italy 
            1.452760258 
            1.15 
            2461 
         
        
            South Korea 
            1.518072203 
            0.78 
            1772 
         
        
            France 
            0.780405486 
            1.15 
            1689 
         
        
            Canada 0.891873641 1.15 1603  
        
            Netherlands 
            1.367043877 
            1.23 
            1344 
         
        
            Spain 
            0.756411262 
            1.18 
            1036 
         
        
            Australia 
            0.862701961 
            1.14 
            1034 
         
        
            Switzerland 
            1.314414337 
            1.37 
            930 
         
        
            Sweden 
            1.304348621 
            1.38 
            879 
         
        
            Israel 
            1.55203224 
            1.29 
            657 
         
        
            Singapore 
            2.213749517 
            1.36 
            595 
         
     
« Back to figure 3 
Figure 4 - Scatterplot of ARC and SI for top 16 productive countries in nanomedicine 2004-2010 
 
        
            Country 
            SI 
            ARC 
            N pub 
         
     
    
        
            United States 
            1.240741425 
            1.217712841 
            17288 
         
        
            China 
            1.680308098 
            0.900848939 
            7157 
         
        
            Germany 
            1.014607687 
            1.08563881 
            3603 
         
        
            Japan 
            1.005182004 
            0.771317169 
            3373 
         
        
            United Kingdom 
            0.683914889 
            1.089460675 
            2548 
         
        
            South Korea 
            1.78696199 
            0.866812872 
            2464 
         
        
            France 
            0.814752749 
            1.014334864 
            2083 
         
        
            India 
            1.252785756 
            0.744606013 
            1766 
         
        
            Canada 0.724860321 1.039741754 1539  
        
            Italy 
            0.712603192 
            0.831716032 
            1426 
         
        
            Spain 
            0.781870193 
            0.952083753 
            1265 
         
        
            Taiwan 
            1.444283234 
            0.801319882 
            1251 
         
        
            Singapore 
            3.206307659 
            1.115050624 
            1018 
         
        
            Switzerland 
            1.176112207 
            1.087550896 
            983 
         
        
            Netherlands 
            0.763752608 
            1.184193746 
            887 
         
        
            Australia 
            0.593994116 
            1.076570374 
            841 
         
     
« Back to figure 4 
Figure 10 - Influence of RMNI on the Development of the Fields of Regenerative Medicine and Nanomedicine 
Extent to which researchers feel RMNI has had a positive influence on the development of the fields of:
 
        
            Regenerative medicine in Canada 
            Nanomedicine in Canada 
            Regenerative medicine internationally 
            Nanomedicine internationally 
         
     
    
        
            No influence (1) 
            0 
            3% 
            1% 
            4% 
         
        
            2 
            0 
            6% 
            1% 
            4% 
         
        
            3 
            8% 
            4% 
            24% 
            19% 
         
        
            4 
            33% 
            22% 
            25% 
            21% 
         
        
            Great influence (5) 
            47% 
            33% 
            29% 
            14% 
         
        
            DK/NA 
            11% 
            32% 
            19% 
            38% 
         
     
« Back to figure 10 
Figure 13 – RMNI-Funded Researchers’ Opinions on Multi/Transdisciplinary Research 
 
        
              
            DK/NA 
            Disagree 
            Neither agree/disagree 
            Agree 
         
     
    
        
            The multi/transdisciplinary aspect of my research: 
              
         
        
            Led to research outcomes that would not have occurred without that kind of collaboration 
            5% 
            6% 
            5% 
            84% 
         
        
            Produced benefits that outweighed any challenges 
            5% 
            2% 
            9% 
            84% 
         
        
            Was necessary to accomplish the research objectives 
            4% 
            5% 
            0 
            91% 
         
        
            I would participate in multi/transdisciplinary research again 
            1% 
            2% 
            0 
            97% 
         
        
            I would encourage other researchers to participate in multi/transdisciplinary research 
            0 
            2% 
            3% 
            95% 
         
     
« Back to figure 13 
Figure 14 – RMNI-Funded Researchers’ Opinions on Team Collaboration 
 
        
              
            DK/NA 
            Disagree 
            Neither agree/disagree 
            Agree 
         
     
    
        
            After the grant, I kept in regular contact with other team members 
            13% 
            6% 
            1% 
            80% 
         
        
            After the grant, the team continued to collaborate as a multi/transdisciplinary group 
            16% 
            9% 
            5% 
            70% 
         
        
            Overall, my RMNI grant facilitated more collaboration with researchers from different disciplines than would have occurred through other grant funding 
            5% 
            3% 
            12% 
            80% 
         
        
            Team members frequently shared information with each other 
            3% 
            5% 
            11% 
            81% 
         
        
            There was trust among team members 
            4% 
            2% 
            8% 
            86% 
         
        
            Team members capitalized on the different disciplinary perspectives 
            3% 
            8% 
            5% 
            84% 
         
        
            Team members were open to innovation 
            3% 
            0 
            9% 
            88% 
         
        
            Conflicts among team members were effectively resolved 
            30% 
            6% 
            13% 
            51% 
         
        
            Overall, team collaboration was effective 
            5% 
            5% 
            4% 
            86% 
         
        
            The team had or achieved a common understanding of the research objectives 
            2% 
            5% 
            7% 
            86% 
         
        
            Prior to joining the team, I had an understanding of the other collaborating disciplines 
            0 
            8% 
            8% 
            84% 
         
        
            My institution was supportive of my involvement in the multi/transdisciplinary research team 
            0 
            6% 
            11% 
            83% 
         
     
« Back to figure 14 
Figure 16 - Usefulness of RMNI Workshops for Researcher Attendees 
 
        
              
            Not at all useful (1) 
            2 
            3 
            4 
            Very useful (5) 
            DK/NA 
         
     
    
        
            Provided learning opportunities 
            0 
            4% 
            13% 
            46% 
            38% 
            0 
         
        
            Presented relevant information pertaining to my research 
            0 
            4% 
            29% 
            33% 
            33% 
            0 
         
        
            Encouraged me to apply for RMNI funding 
            4% 
            17% 
            21% 
            29% 
            25% 
            4% 
         
        
            Encouraged research collaborations with other attendees 
            0 
            8% 
            38% 
            33% 
            21% 
            0 
         
        
            Opened new directions for my research 
            0 
            25% 
            25% 
            29% 
            17% 
            4% 
         
     
« Back to figure 16 
Figure 17 – RMNI-funded researchers’ satisfaction with peer review 
RMNI researchers compared to 2011 CIHR International Review survey respondents (Successful applicants; Theme included pillar 1; Applications included team and/or catalyst grants)
 
        
              
              
            DK/NA 
            Dissatisfied 
            Neither satisfied/dissatisfied 
            Satisfied 
         
     
    
        
            Clarity of the evaluation criteria 
            RMNI overall 
            4% 
            0 
            11% 
            85% 
         
        
            CIHR International Review 
            0 
            32% 
            15% 
            53% 
         
        
            Usefullness of the written feedback 
            RMNI overall 
            8% 
            4% 
            14% 
            74% 
         
        
            CIHR International Review 
            0 
            29% 
            13% 
            58% 
         
        
            Clarity of the rating system 
            RMNI overall 
            6% 
            0 
            12% 
            82% 
         
        
            CIHR International Review 
            0 
            28% 
            18% 
            54% 
         
        
            Quality of peer review judgements 
            RMNI overall 
            6% 
            1% 
            4% 
            89% 
         
        
            CIHR International Review 
            0 
            36% 
            11% 
            53% 
         
        
            Consistency of peer review judgements 
            RMNI overall 
            8% 
            3% 
            11% 
            78% 
         
        
            CIHR International Review 
            1% 
            52% 
            12% 
            35% 
         
     
« Back to figure 17 
Figure 19 – RMNI-Funded Researchers’ Opinions on the Impact of the Absence of RMNI 
In the absence of future RMNI funding opportunities, RMNI funded researchers would:
 
        
              
            Strongly disagree (1) 
            Disagree (2) 
            Neither (3) 
            Agree (4) 
            Strongly agree (5) 
            DK/NA 
         
     
    
        
            Have more difficulty obtaining funding 
            4 
            14 
            21 
            35 
            24 
            2 
         
        
            Have more difficulty advancing their career 
            7 
            15 
            21 
            36 
            14 
            7 
         
        
            Be able to sustain their research program 
            1 
            22 
            26 
            39 
            10 
            1 
         
        
            Leave the field of health research 
            32 
            44 
            14 
            3 
            0 
            7 
         
     
« Back to figure 19 
RMNI logic model 
Inputs 
    CIHR human and financial resources  
    Partner human, financial and in-kind resources  
    Researcher time, knowledge and expertise  
 
Activities 
    Communications with the RM & N research community  
    Competition and post-award management  
    Convening focused workshops and meetings  
    Communications with other government and NGO partners  
 
Outputs 
    Funded trans/multidisciplinary collaborative research projects  
    Funded research projects with potential for generating high impact results  
    Relevant workshops and meetings held  
    Exchange of information with government and NGO partners  
 
Outcomes 
Immediate 
    Capacity development in the fields of RM & N  
    Enhanced approaches to understanding and resolving RM & N health issues through trans/multidisciplinary collaboration  
    Generation of innovative tools, techniques, proposals, devices, inventions or methodologies  
    Development of a collaborative RM & N research network  
    Coordinated policy and funding decisions  
    Knowledge translation  
 
Intermediate 
    Canada has a strong and growing presence in the fields of regenerative medicine and nanomedicine  
    Greater awareness of potential impact of RM & N research  
    Knowledge translation  
 
Long-term 
    Improved quality of life for individuals, their families, and populations  
    Knowledge translation  
 
« Back to RMNI logic model diagram 
                           
                           
                           
                           
                           
                           
                           
                        
                                                              
                                          
                        
        
                  
		
            Date modified:  
            
              
				  2013-09-27